安杰思: 安杰思关于变更保荐代表人的公告

Group 1 - The company, Hangzhou Anjisi Medical Technology Co., Ltd., has announced a change in its sponsoring representatives for its initial public offering (IPO) on the Sci-Tech Innovation Board [1][2] - The original sponsoring representative, Mr. Wang Peng, is unable to continue due to work arrangements, and Mr. Yu Qidong has been appointed as his replacement [1][2] - The new sponsoring representatives for the company's IPO project will be Mr. Xu Feng and Mr. Yu Qidong, ensuring the continuity of the ongoing supervision work [1][2] Group 2 - The change in sponsoring representatives will not affect the conclusions of the documents previously issued by the sponsoring institution and representatives [2] - The board of directors expresses gratitude for Mr. Wang Peng's contributions during the IPO and ongoing supervision period [2] - Mr. Yu Qidong, the new representative, has a good professional record and has participated in various projects, including the IPO project of Anjisi [2]